Best in Biotech 8 Jan 2025
Ten drugs to watch in 2025: will these therapies become blockbusters?
Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate’s latest report.
- Latest Posts
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
Partnering 2030: Biopharma Report
Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.
Expert Advice 6 Jan 2025
What to look for in a biotech incubator
Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one?
News and Trends 2 Jan 2025
A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development
Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.
Best in Biotech 30 Dec 2024
Six biotech companies leading the way in India
Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce.
ADVERTISEMENT
ADVERTISEMENT
Podcast 27 Dec 2024
[Rebroadcast] The power of natural killer cells
In Depth 25 Dec 2024
When biotech makes Christmas miracles a reality
Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.
Best in Biotech 23 Dec 2024
The best biotech movies to watch this winter
Dive into the world of biotech cinema this holiday season! Our list of biotech movies offers the perfect blend of science and entertainment.
Podcast 20 Dec 2024
Looking at 2025 biotech trends with SoftBank Vision Fund
In our discussion with John Cassidy from SoftBank Vision Fund, we cover investment trends within life sciences, the European health and biotech scene
In Depth 19 Dec 2024
After decades of stagnation, is Japan’s biopharma industry set for an upswing?
Discover the history of Japan’s biopharma industry and whether it is now set for an upswing after years of stagnation from economic troubles.
In Depth 18 Dec 2024
AI + CRISPR: The explosive fusion that will redefine biotechnology
With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration.
ADVERTISEMENT
